Resistance Pattern of Pseudomonas aeruginosa from Patients with Urinary Tract Infection Attending Urology/Nephrology Clinic of Usmanu Danfodiyo University Teaching Hospital, Sokoto
Abstract
Background: Pseudomonas aeruginosa is among the most common organisms implicated in causing Healthcare associated infection. It is intrinsically resistant to many antimicrobial agents and can develop resistance even during treatment both of which compromise treatment of infection caused by this agent. Aim: To isolate Pseudomonas aeruginosa and ascertain its resistance pattern from the urine of patient attending Urology/Nephrology clinic in Usmanu Danfodiyo University Teaching Hospital, Sokoto. Methodology: The study was a hospital based cross-sectional study targeting Gram negative rods from patients with urinary tract infection. The urine was collected and cultured on Cystein Lactose Electrolyte Deficient (CLED) and blood agar. All non-lactose fermenters on CLED were subjected to biochemicals (oxidase test, motility, Triple sugar iron agar, urea, citrate and pigment production on Mueller Hinton Agar) for identification. The confirmed Pseudomonas aeruginosa is further subjected to antimicrobial susceptibility testing using modified Kirby-Bauer according to Clinical and Laboratory Standard Institute (2023) guidelines. Results: The prevalence of Pseudomonas aeruginosa from clinical isolates was found to be 8.5%. Amikacin and Meropenem appeared to be the most sensitive antibiotics 29.4% each and highest level of resistance was seen in Ceftazidime and Levofloxacin 70.6% each. Ciprofloxacin had 58.8%, Cefepime, Piperacillin-tazobactam and Gentamicin had 52.9% and imipenem 35.3%.…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.